3 New Strong Buy Ratings from Top-Rated Analysts: 04/30/2026

By Jessie Moore, Stock Researcher and Writer
April 30, 2026 5:48 AM UTC
3 New Strong Buy Ratings from Top-Rated Analysts: 04/30/2026

These aren’t necessarily household names — but there’s a compelling reason to add each and every one to your watchlist. All sourced using our Zen Ratings system. You’re welcome.

  • Sonos (NASDAQ: SONO) — Top-rated consumer electronics play with 43% upside potential
  • Kontoor Brands (NYSE: KTB) — Wrangler and Lee owner boasts 74% return on equity
  • Veracyte (NASDAQ: VCYT) — Diagnostics standout shining bright in struggling biotech sector

P.S. Get more alerts like this daily … Try WallStreetZen Premium.

 


A note from our sponsors...

"This stock has a 93% history of soaring, every spring"

One of the most popular stocks in America has a 100% history of rising on one particular date - every single spring.

In fact, it's gone up beginning this ONE specific day - year after year - at a rate fast enough to double your money in 12 months.

Click here to see the name of the stock, free of charge.


1. Sonos (NASDAQ: SONO)

Sonos is a global powerhouse in multi-room audio, designing and selling premium sound systems worldwide. With fresh product launches like the Sonos Play and Era 100 SL — backed by 17.2% profit margins and rock-solid cash flow — this consumer electronics leader is turning up the volume on growth.

Zen Rating: A (Strong Buy)see full analysis

Recent Price: $14.49 — get current quote

Max 1-year forecast: $21.00

Why we're watching:

  • Analyst support: Unanimous positive sentiment with 2 Strong Buy ratings and 1 Hold rating from 3 analysts covering the stock. See the ratings
  • Rosenblatt's Steve Frankel (a top 6% rated analyst) maintains a Strong Buy rating with a $21 price target, representing +43.44% upside potential.
  • Jefferies' Brent Thill (a top 6% rated analyst) maintains a Strong Buy rating with a $21 price target, noting in his 2026 sector preview that while AI monetization will be gradual, selective opportunities like Sonos offer compelling value.
  • Morgan Stanley's Erik Woodring (a top 2% rated analyst) upgraded the stock to Hold with a $17 price target, acknowledging improving fundamentals.
  • Industry ranking context: SONO is currently the #1 highest-rated stock in the Consumer Electronic industry, which has an Industry Rating of B.
  • Zen Rating highlights: SONO earns an A or Strong Buy rating. This is serious, y’all. Stocks with A ratings have historically generated over 30% annual returns. 
  • Component Grades: SONO stands out with an A-rated Financials component driven by strong profit margins and cash flow generation, complemented by B grades in Growth, Sentiment, and AI, positioning it as the top-rated consumer electronics play. See all 7 Zen Component Grades here

2. Kontoor Brands (NYSE: KTB)

Kontoor Brands is the apparel giant behind the iconic Wrangler and Lee labels, distributing across global markets. A bold new partnership with Chaco for an adventure-ready apparel and footwear line is expanding its reach — all while the company flexes a jaw-dropping 74% return on equity.

Zen Rating: A (Strong Buy) see full analysis

Recent Price: $72.05 — get current quote

Max 1-year forecast: $131.00

Why we're watching:

  • Analyst support: Strong bullish consensus with 6 Strong Buy ratings and 1 Hold rating from 7 analysts covering the stock. See the ratings
  • Wells Fargo's Ike Boruchow (a top 5% rated analyst) maintains a Strong Buy rating with a $100 price target, citing solid sales growth forecast and resilient market fundamentals.
  • BTIG's Robert Drbul (a top 11% rated analyst) maintains a Strong Buy rating with a $100 price target, expressing confidence in the growth trajectory reinforced through strategic initiatives including investment in technology.
  • Industry ranking context: KTB is currently the 3rd highest-rated stock in the Apparel Manufacturing industry, which has an Industry Rating of A.
  • Zen Rating highlights: KTB ranks in the top 5% of stocks we track based on a rigorous 115-factor review. (It’s better-rated than even NVDA!)
  • Component Grades: KTB excels with an A-rated Value component, complemented by B grades in Growth and Financials, while the company's 30.96% earnings growth significantly outpaces the market average. See all 7 Zen Component Grades here

3. Veracyte (NASDAQ: VCYT)

Veracyte is a diagnostics innovator delivering genomic testing breakthroughs like the Afirma Genomic Sequencing Classifier and Xpression Atlas for patients facing uncertain results. Trading at $33.47 after a +3.56% daily pop, the stock has surged 49.71% off its 52-week low — fueled by an impressive 29.3% profit margin.

Zen Rating: A (Strong Buy)see full analysis

Recent Price: $33.47 — get current quote

Max 1-year forecast: $48.00

Why we're watching:

  • Analyst support: Positive coverage with 3 Strong Buy ratings, 1 Buy rating, 1 Hold rating, and 1 Strong Sell rating from 6 analysts, with consensus leaning bullish. See the ratings
  • For example, Jefferies' Tycho Peterson (a top 18% rated analyst) initiated coverage with a Strong Buy rating and $45 price target, representing +32.94% upside potential.
  • Analyst actions show recent bullish activity with Jefferies initiating coverage in April 2026, signaling renewed institutional interest in the stock ahead of Q1 earnings on May 12.
  • Industry ranking context: VCYT is currently the 7th highest-rated stock in the Biotech industry.
  • Zen Rating highlights: VCYT has an overall Zen Rating of A — the highest tier of stocks we track, and a class of stocks that has historically returned 32.52% annually. 
  • Component Grades: Looking at the Component Grades that shape the overall rating, VCYT shines with an A grade for Growth and above-average Bs for Financials, Safety, Sentiment, and Value. See all 7 Zen Component Grades here

What to Do Next?

Want to get in touch? Email us at news@wallstreetzen.com.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.